Helixmith Co., Ltd (KOSDAQ:084990)
4,120.00
-60.00 (-1.44%)
Jun 30, 2026, 3:30 PM KST
Helixmith Market Cap
Helixmith has a market cap or net worth of 189.71 billion as of June 30, 2026. Its market cap has increased by 31.42% in one year.
Market Cap
189.71B
Enterprise Value
108.65B
Revenue
2.22B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,120.00
Market Cap Chart
Since December 29, 2005, Helixmith's market cap has decreased from 238.64B to 189.71B, a decrease of -20.50%. That is a compound annual growth rate of -1.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 189.71B | -33.76% |
| Dec 30, 2025 | 286.41B | 130.37% |
| Dec 30, 2024 | 124.33B | -51.50% |
| Dec 28, 2023 | 256.37B | -35.45% |
| Dec 29, 2022 | 397.14B | -53.54% |
| Dec 30, 2021 | 854.88B | -3.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genomictree | 251.85B |
| BINEX | 216.56B |
| GC Cell | 197.76B |
| EASY BIO,Inc. | 196.84B |
| HLB Therapeutics | 191.61B |
| Anterogen.Co.,Ltd. | 189.02B |
| Bioneer | 160.54B |
| JETEMA, | 158.66B |